| Product Name | MF | CAS | Details |
|---|
| A-9758 | C25H23Cl2F3N2O3 | 2055271-22-0 | Details |
| β3-AR agonist 1 | C22H28N4O4S | 1283125-73-4 | Details |
| BIIL-260 hydrochloride | C30H31ClN2O3 | 192581-24-1 | Details |
| β-NF-JQ1 | C45H42ClN5O6S | 2380000-55-3 | Details |
| AHR antagonist 5 | C25H25ClFN7 | 2247953-39-3 | Details |
| AFP464 free base | C22H23F3N4O3 | 468719-52-0 | Details |
| BACE1-IN-4 | C21H23F2N5O4S2 | 2361157-92-6 | Details |
| BAY-784 | C29H26ClF4N3O5S2 | 1631164-24-3 | Details |
| AMG 487 (S-enantiomer) | C32H28F3N5O4 | 473720-30-8 | Details |
| AM-6494 | C22H21F2N5O3S | 1874232-80-0 | Details |
| AhR modulator-1 | 115039-00-4 | Details |
| 5-A-RU hydrochloride | C9H17ClN4O6 | 134452-11-2 | Details |
| ACHN-975 TFA | C22H24F3N3O6 | 1410809-37-8 | Details |
| MC-4R Agonist 1 | C30H38ClF2N3O2 | 455957-28-5 | Details |
| Anti-parasitic agent 3 | C21H22FN5O3 | 2366983-10-8 | Details |
| Antimicrobial Compound 1 | C18H30BrNO2 | 15237-83-9 | Details |
| ALK-IN-5 | C24H25FN6O3 | 2351929-66-1 | Details |
| AR-A 2 | C27H36N4O2 | 220051-79-6 | Details |
| AR453588 | C25H25N7O2S2 | 1065609-00-8 | Details |
| AZ12601011 | C19H15N5 | 2748337-86-0 | Details |
| AMPK activator 1 | C32H33F3N4O3 | 1152423-98-7 | Details |
| Itch-Targeting Compound 1 | C25H36ClN3O3 | 793674-76-7 | Details |
| 2-Deoxy-2’-deoxy-5’-(4,4’-dimethoxytrityl)uridine | C30H30N2O6 | 151503-26-3 | Details |
| 8-Aza-2’-deoxyguanosine | C9H12N6O4 | 4546-73-0 | Details |
| 2’-Deoxy-2’-fluoro-3’,5’-bis-O-TBDMS-uridine | C21H39FN2O5Si2 | 139878-36-7 | Details |
| 5’-O-TBDPS-2,2’-anhydrouridine | C25H28N2O5Si | 175013-46-4 | Details |
| 5-Aminomethyl-2’,3’-di-O-isopropylidene 2-thiouridine | C13H19N3O5S | 1428903-07-4 | Details |
| N6-Ethyl-2’-deoxyadenosine | C12H17N5O3 | 136050-93-6 | Details |
| 1-[[2-Hydroxy-1-(hydroxy ? methyl)ethoxy]methyl]cytosine | C8H13N3O4 | 87892-46-4 | Details |
| 2’,3’,5’-Tri-O-acetyl-6-S-methyl-6-thio-guanosine | C17H21N5O7S | 80681-58-9 | Details |
| N4-Benzoyl-5’-O-DMT-3’-O-(2-methoxyethyl)-5-methylcytidine | C41H43N3O9 | 256223-98-0 | Details |
| 4’-alpha-C-Allyl-2’,3’-bis(O-t-butyldimethylsilyl)uridine | C24H44N2O6Si2 | 512184-18-8 | Details |
| 3’-O-(t-Butyldimethylsilyl)-2’-O-(2-methoxyethyl) uridine | C18H32N2O7Si | 1345716-52-0 | Details |
| 2’-Deoxy-N2,N2-diethyl ? guanosine | C14H21N5O4 | 236389-19-8 | Details |
| 5’-Deoxy-5’-(4-morpholinyl)thymidine | C14H21N3O5 | 2305415-93-2 | Details |
| Saralasin acetate(34273-10-4 free base) | C44H71N13O13 | 39698-78-7 | Details |
| 2’-O-Hexadecanyl guanosine | C26H45N5O5 | 2382942-29-0 | Details |
| Cefalonium Dihydrate(5575-21-3 free base) | C20H20N4O6S2 | 1385046-35-4 | Details |
| N1-Methyl ara-uridine | C10H14N2O6 | 17676-62-9 | Details |
| 2’,3’-Isopropylidene-5-hydroxyuridine | C12H16N2O7 | 20406-82-0 | Details |
| 2’-Deoxy-2’-fluoro-N6-methyladensoine | C11H14FN5O3 | 134444-58-9 | Details |
| Tidembersat | C20H19F2NO4 | 175013-73-7 | Details |
| 7-Methoxy-2,2,4-trimethyl-1,2,3,4-tetrahydroquinoline | C13 H19 N O | 41381-73-1 | Details |
| 3’-N-Acetyl-3’-amino-3’-deoxy-2’,5’-di-O-acetyluridine | C15H19N3O8 | 2305416-09-3 | Details |
| 2’-Deoxy-2’-fluoro-5-methyl-4’-thio-a-D-arabinouridine | C10H13FN2O4S | 294868-24-9 | Details |
| Anticonvulsant agent 1 | C10H14F2N2O2 | 357336-17-5 | Details |
| N2-Isobutyryl-(S)-9-(2,3-dihydroxypropyl)-guanine | C12H17N5O4 | 885322-02-1 | Details |
| 3’-Deoxy-5’-O-(4,4’-dimethoxytrityl)-3’-fluorouridine | C12H4Cl4F3N5O4 | 129015-60-7 | Details |
| 2’-Bromo-2’-deoxy-5-fluorouridine | C9H10BrFN2O5 | 32791-82-5 | Details |
| 3’-Deoxy-5’-O-(4,4’-dimethoxytrityl)-3’-fluorouridine-2’-CED-phosphoramidite | C12H5Cl3F3N5O4 | 129015-63-0 | Details |
| 2’-Chloro-N6-benzyl adenosine | C17H18ClN5O4 | 23558-62-5 | Details |
| 8-Methyl-2’-deoxyadenosine | C11H15N5O3 | 85562-60-3 | Details |
| 3’,5’-Di-O-acetyl-2’-deoxy-5,N3-dimethyl uridine | C15H20N2O7 | 144874-49-7 | Details |
| 3’,5’-Di-O-acetyl-2’-deoxy-N3-methyl uridine | C14H18N2O7 | 2305416-14-0 | Details |
| 5’-Deoxy-5’-N-(2-chloroethyl)aminothymidine | C12H18ClN3O4 | 2305415-99-8 | Details |
| 2’,3’,5’-Tri-O-acetyl-N3-methyluridine | C16H20N2O9 | 64623-26-3 | Details |
| 5’-Deoxy-5’-N,N-diethylaminothymidine | C14H23N3O4 | 2305415-88-5 | Details |
| 2’,3’,5’-Tri-O-acetyl-5,N3-dimethyl uridine | C17H22N2O9 | 201421-00-3 | Details |
| 5’-Deoxy-5’-N,N-dimethylaminothymidine | C12H19N3O4 | 162466-79-7 | Details |
| N2-iso-Butyroyl-5’-O-DMT-3’-O-(methoxyethyl)guanosine | C38H43N5O9 | 256224-05-2 | Details |
| 3’-O-t-Bulyldimethylsilyl-4’-C-hydroxymethylthymidine | C17H30N2O6Si | 139887-99-3 | Details |
| 4’-Methylthymidine | C11H16N2O5 | 139925-84-1 | Details |
| 1’,2’,3’,5’-Tetra-O-benzoyl-2’-beta-C-ethynyl-D- ribofuranose | C35H26O9 | 1567898-12-7 | Details |
| N2-iso-Butyroyl-3’-O-(methoxyethyl)guanosine | C17H25N5O7 | 256224-04-1 | Details |
| 5-Azidomethyl-2’-beta-methyl-2’,3’,5’-tri-O-benzoyluridine | C32H27N5O9 | 2305416-08-2 | Details |
| 5’-O-(4,4’-Dimethoxytrityl)-3’-O-methyluridine | C31H32N2O8 | 127212-40-2 | Details |
| 2’-Deoxy-N6-(3-methoxybenzyl)adenosine | C18H21N5O4 | 1947400-98-7 | Details |
| 3’-O-(2-Methoxyethyl)-5-methyluridine | C13H20N2O7 | 303197-29-7 | Details |
| 2’-Deoxy-N6-cyclopentyladenosine | C15H21N5O3 | 170711-45-2 | Details |
| 2’-Deoxy-N2-isopropyl guanosine | C13H19N5O4 | 201528-73-6 | Details |
| 2-Chloro-N6-cyclopentyl 2’-deoxy- ? adenosine | C15H20ClN5O3 | 215108-39-7 | Details |
| 3-Formylindole-2’-deoxyriboside | C14H15NO4 | 460355-03-7 | Details |
| 2-O-benzoyl-3-O-t-butyldiphenylsilyl-L-threonolactone | C27H28O5Si | 1446785-28-9 | Details |
| 3’-Azido-2’,3’-dideoxy-5-hydroxyuridine | C9H11N5O5 | 111495-90-0 | Details |
| 3’,5’-Bis(O-t-butyldimethylsilyl)-4’-C-hydroxymethyl thymidine | C23H44N2O6Si2 | 179178-45-1 | Details |
| 2-Methyl-2’-deoxyadenosine | C11H15N5O3 | 110952-90-4 | Details |
| 3’-O-(t-Butyldimethylsilyl)-2’-O-(2-methoxyethyl)-5-methyluridine | C19H34N2O7Si | 1221967-92-5 | Details |
| 2’-Deoxy-N2-cyclopentyl guanosine | C15H21N5O5 | 1353757-90-0 | Details |
| 5’-Deoxy-5’-furfurylamino ? thymidine | C15H19N3O5 | 2305416-15-1 | Details |
| 2’-Deoxy-N6-(4-methoxybenzyl)adenosine | C18H21N5O4 | 157640-47-6 | Details |
| 5-Azidomethyl-2’,3’,5’-tri-O-benzoyl uridine | C31H25N5O9 | 1884334-72-8 | Details |
| 2’-O-Acetyl-5’-O-benzoyl-3’-O-methyl-5-methyluridine | C20H22N2O8 | 2305415-91-0 | Details |
| Alverine hydrochloride | C20H28ClN | 5982-87-6 | Details |
| Fenebrutinib HCl | C37H45ClN8O4 | 2128304-54-9 | Details |
| VCH-916 free acid(1200133-34-1 free base) | C26H37NO4S | 914778-92-0 | Details |
| 3’-Deoxy-N6-ethyladenosine | C12H17N5O3 | 3608-60-4 | Details |
| N2-iBu-5’-O-DMTr-2’-O-hexadecanyl guanosine | C51H69N5O8 | 2382942-31-4 | Details |
| N2-iso-Butyryl-8-azaguanosine | C13H18N6O6 | 2328168-83-6 | Details |
| 3’-O-(2-Methoxyethyl)uridine | C12H18N2O7 | 870599-31-8 | Details |
| 2’-Deoxy-5-methoxyuridine | C10H14N2O6 | 37805-95-1 | Details |
| 8-Methyl-2’-deoxyguanosine | C11H15N5O4 | 85819-69-8 | Details |
| 2’-O-Hexadecanyl adenosine | C26H45N5O4 | 211690-85-6 | Details |
| LTD4 antagonist 1 | C31H32F3N3O5S | 136564-67-5 | Details |
| 2-Amino-2’,3’-bis-O-(2-methoxyethyl) ? adenosine | C16H26N6O6 | 847647-19-2 | Details |
| Bombesin acetate(31362-50-2 free base) | C73H114N24O20S | 1222319-87-0 | Details |
| 4'-Ethynyl-2'-deoxyadenosine | C12H13N5O3 | 306305-07-7 | Details |
| Asthma relating compound 1 | C17H19N3O3S2 | 120165-51-7 | Details |
| A 83-01 sodium salt | C25H20N5NaS | 2828431-89-4 | Details |
| Thymosin β4 acetate(75591-33-4 free base) | 1346423-89-9 | Details |
| ABT-546 | C30H48N2O6 | 212481-66-8 | Details |
| Product Total： Product Page： | ||||
| 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 | ||||